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Psychometric Validation of the Dysexecutive Questionnaire (DEX)  
  
Abstract 
This study reported on the validation of the psychometric properties, the factorability, 
validity, and sensitivity of the Dysexecutive Questionnaire (DEX) in three clinical and 
nonclinical samples.  A mixed sample of 997 participants—community (n = 663), psychiatric 
(depressed [n = 92] and anxious [n = 122]), and neurologically impaired (n = 120)—
completed self-report questionnaires assessing executive dysfunction, depression, anxiety, 
stress, general self-efficacy, and satisfaction with life. Prior to analyses the data were 
randomly split into two subsets (A and B).  Exploratory factor analysis performed on Subset 
A produced a three-factor model (Factor 1: Inhibition, Factor 2: Volition, and Factor 3: Social 
Regulation) in which 15 of the original 20 items provided a revised factor structure that was 
superior to all other structures. A series of confirmatory factor analyses performed on Subset 
B confirmed that this revised factor structure was valid and reliable. The revised structure, 
labeled the DEX-R, was found to be a reliable and valid tool for assessing behavioral 
symptoms of dysexecutive functioning in mixed community, psychiatric, and neurological 
samples. 
 
Keywords: DEX-R, psychometric, validation, dysexecutive syndrome, mood and anxiety 
disorders 
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Introduction 
Executive functioning is typically measured using clinical interviews, neuroimaging 
techniques, neuropsychological assessment, or standardized questionnaires.  Each 
measurement approach has its strengths and limitations, and all are associated with a certain 
degree of error.  Clinical interviews provide subjective, verbal accounts of deficits in 
executive functioning in a person’s life.  However, one of the major limitations associated 
with clinical interviews is that they can be time consuming, which, in the context of the 
present research, is not conducive to ease of data collection.  Furthermore, due to their 
subjective nature it can be laborious to compare data across large samples.  While 
neuroimaging is the most accurate way to measure neuroanatomical structures its ability to 
measure the severity and nature of hypothetical cognitive constructs, such as executive 
functioning, is arguable.  Some of the most commonly used batteries of executive functioning 
include the Behavioral Assessment of the Dysexecutive Syndrome (Alderman, Burgess, 
Emslie, Evans, & Wilson, 2003), the Delis-Kaplan Executive Function System (Delis, 
Kaplan, & Kramer, 2001), the modified Six Elements Test (Burgess et al., 1996), the Test of 
Everyday Attention (Robertson, Ward, Ridgeway, & Nimmo-Smith, 1996), and the Multiple 
Errands Test (Shallice & Burgess, 1991).  While all the above assessment scales have been 
used in the literature the Dysexecutive Questionnaire (DEX) is the focus of this study.  
 
The Dysexecutive Questionnaire 
The frontal lobes are the higher cortical center for executive functioning.  Due to the 
intricate networking of the brain the frontal lobes do not act in isolation when performing 
executive function tasks.  Functions such as planning, attentional control, self-monitoring, and 
evaluation (i.e., considering consequences for one’s actions) appear to be driven by separate 
mechanisms that share underlying neural circuitry (Weingartner, 2000).  The term “Frontal 
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Lobe Syndrome” (The Dysexecutive Syndrome) was originally used to describe the collective 
dysexecutive symptoms observed in neurological patients.  It was specifically defined as “an 
amorphous varied group of deficits resulting from diverse aetiologies, different locations and 
variable extents of abnormalities” (Stuss & Benson, 1984, p. 3).  The DEX (Burgess et al., 
1996) is a qualitative and quantitative self-report measure designed to fractionate daily 
functioning into sub-scales of dysexecutive functioning.  Although the DEX was initially 
developed to assess impairment in frontal lobe patients the measure potentially allows for 
fairly specific comparisons of executive dysfunction across different clinical populations.    
The DEX was developed to supplement and provide ecological validity for the 
Behavioral Assessment of the Dysexecutive Syndrome (BADS; Wilson, Alderman, Burgess, 
Emslie, & Evans, 1996).  However, despite widespread use of the DEX in the literature there 
are a number of limitations relating to its use. First, no study has conducted a Confirmatory 
Factor Analysis (CFA) to confirm the psychometric properties of the questionnaire.  Second, 
all previous factor analytic studies have used relatively restricted sample sizes and types.  
Third, despite some similarities in factor structures across studies the factor structure of the 
DEX remains ambiguous.  Fourth, previous reliability and validity analyses are scant.  For 
example, only one previous study (Bennett, Ong, & Ponsford, 2005) has reported on the 
internal consistency of the DEX.  Finally, although prior research has validated its use in a 
variety of neurological samples (Bennett et al., 2005; Bogod, Mateer, & MacDonald, 2003; 
Burgess, 1997; Wilson et al., 1996) and in an opiate-dependent sample (Mooney, Walmsley, 
& McFarland, 2006), no study has examined the extent to which the scale can effectively 
measure executive dysfunction in psychiatric populations.   
Despite these limitations the DEX remains widely used in the research literature (Bajo 
& Nathaniel-James, 2001; Bennett et al., 2005; Bogod et al., 2003; Chaytor, Schmitter-
Edgecombe, & Burr, 2006; Norris & Tate, 2000), and is a promising measure of executive 
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functioning across a variety of samples.  Therefore, further research is warranted to ascertain 
the psychometric properties and factor structure of the DEX across community samples and 
psychiatric outpatients. 
 Four studies have explored the factor structure of the DEX using exploratory factor 
analysis (EFA) in a variety of samples (e.g., neurological, opiate-dependent, and normative); 
however, these studies have used limited sample sizes and types (Burgess, Alderman, Evans, 
Emslie, & Wilson, 1998; Chan, 2001; Mooney et al., 2006; Wilson et al., 1996).  
Furthermore, whilst these studies provide evidence of some consistency between factor 
structures there remains a lack of consensus regarding a robust and parsimonious factor 
structure.  We reviewed each of these factor analytic studies, the results of which are 
presented in Table 1.  
------------------------- 
Insert Table 1 about here 
--------------------------- 
A preliminary standardization study of the DEX examined a sample of 78 neurological 
patients (M = 38.8 years) of various aetiologies and 216 control participants (M = 46.6 years) 
recruited from a variety of sources in the United Kingdom (UK) and United States of America 
(USA) (Wilson et al., 1996).   Initial EFA of the DEX for the neurological sample only 
showed that the symptoms associated with dysexecutive syndrome could be behaviorally 
fractionated into three general factors: (1) behavioral; (2) cognitive; and (3) emotional 
symptoms. These three factors account for approximately 50% of the variance (see Table 1).   
 In 1998 Burgess et al. conducted a more comprehensive EFA of the DEX using the 
same UK/USA sample as Wilson et al. (1996), with an additional 14 participants in the 
neurological cohort.  Results revealed that a five-factor model was adequate in explaining the 
correlations among the 20 items.  Varimax rotations revealed a five-factor solution, with these 
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explaining 67.2% of the variance.  Burgess et al. labeled Factor 1 as “Disinhibition” or the 
inability to inhibit a pre-potent response.  Factor 2 included items that related to the patients’ 
inability to formulate appropriate goal-oriented plans and follow complex behavioral 
sequences and was labeled “Intentionality”.  Factor 3 described the memory disturbances 
associated with dysexecutive syndrome and was coined “Executive Memory”.  Factors 4 and 
5 related to the positive and negative emotions associated with dysexecutive syndrome and 
were consequently categorized as “Positive Affect” and “Negative Affect” respectively (see 
Table 1). 
 In another study Mooney et al. (2006) found a four-factor solution was the most 
parsimonious, in contrast to the factor solutions of the DEX found by Burgess et al. (1998) 
and Chan (2001). Mooney et al. argued that the five-factor solutions were theoretically 
uninterpretable and contained multiple ambiguous items. Given this, Mooney et al. concluded 
that their four-factor solution was the most favorable, with 54% of the variance being 
accounted for by the solution. The four factors are “Inhibition”, “Intention”, “Social 
Regulation”, and “Abstract Problem Solving”.  This solution also contained two ambiguous 
items (i.e., item 5: euphoria, and item 16: inability to inhibit responses); however, item 
ambiguity was present in all three factor solutions described above (Burgess et al., 1998; 
Chan, 2001; Mooney et al., 2006).  Item 10 (variable motivation) was also left out of the final 
factor structure.  
There is currently a paucity of studies examining the factor structure of the DEX. All 
previous (EFA) studies yielded varying structures of between three and five factors (Burgess 
et al., 1998; Chan, 2001; Mooney et al., 2006; Wilson et al., 1996).  However, no CFA 
research has been reported to date.  CFA provides a stringent test of the latent structure of a 
measure, since it allows for the testing of specific hypotheses about data (Tabachnick & 
Fidell, 2007).  Further, CFA explicitly identifies whether items are adequate measures of the 
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underlying construct that the questionnaire is designed to measure (Chou & Bentler, 1995).  
CFA also allows alternative factor models to be compared for best fit to the data.  As CFA is a 
more stringent statistical technique than EFA it should be an essential step in validating the 
DEX.   
Results from previous DEX factor analytic studies are somewhat promising in that 
there appears to be some overlap between factor structures, despite the fact that there are 
some fundamental methodological differences between the studies.  First, previous research 
used different versions of the questionnaire to measure symptoms of executive dysfunction; 
specifically, the DEX-O was used in two studies (Burgess et al., 1998; Chan, 2001), while the 
DEX-S was used in one study (Mooney et al., 2006).  Second, these studies used restricted 
sample sizes, ranging from 49 to 78 participants for populations of interest.   
Although previous EFA research of the DEX has provided some similarity across 
factor structures the factor structures remain ambiguous.  Moreover, despite its widespread 
use the DEX has never been subjected to CFA.  Thus, it is evident that further examination of 
the psychometric properties of this questionnaire is clearly warranted to evaluate the 
consistency and stability of the factor structure of the DEX across a variety of populations, in 
particular in psychiatric outpatients.   
 The current research aimed to address the limitations and gaps in the existing literature 
by further investigating the factor structure of the DEX-S in a diverse sample.  Our study 
aimed to answer the question “Can DEX be generalized across community, psychiatric, and 
neurological samples?”  Given that the findings of previous research were ambiguous in 
relation to a specific factor structure of the DEX, and that there was no a priori basis for a 
specific factor structure for the psychiatric group, no specific hypotheses were given; 
however, it was expected that a three-factor structure would most likely emerge based on 
previous findings.  In addition, different previous models were also compared using CFA. 
8 
PSYCHOMETRIC VALIDATION OF THE DEX 
 
Method 
Participants  
Nine hundred and ninety-seven individuals across three settings participated (51% 
male), comprising a community sample (n = 663), psychiatric sample (depressed patients, n = 
92; anxiety patients, n = 122), and neurologically impaired sample (n = 120).  Psychiatric 
outpatients were recruited from a cognitive behavioral therapy (CBT) unit at a psychiatric 
hospital and, similarly, neurological patients were recruited from the head injuries unit of a 
large public general hospital.   The community sample comprised a mix of university students 
and other individuals.  The majority of participants were born in Australia (81.8%) and spoke 
English at home1 (88.0%). We also collected participants’ actual education level and created 
dummy variables for simplicity of descriptive reporting: participants had completed either 
year 10 or below (15%), year 11-12 (50%), or higher education (35.0%).  Reported 
occupations included students (75.0%), professionals (15.0%), and casual or house-oriented 
workers (10.0%). We chose different samples in order to create a more rigorous and diverse 
DEX testing so that we could then directly compare the groups. This design added strength to 
our study.  Ages ranged from 15 to 72 years (M = 29.7; SD = 13.8) with a median age of 23 
years.  The rejection rate for the clinical sample was less than 5%, while the rejection rate for 
the community sample was 20%. Thus, the total sample had a participant rate of about 80% to 
95%, which was more than adequate.  All patients admitted to the relevant hospital units 
during the recruitment period were approached and less than 5 % decided not to participate. 
This rate of refusal in a hospital setting is expected.  However, in the community group, the 
rate of refusal from university students was less than 10% but the rate of refusal from other 
individuals was about 25%.  Thus, overall, the community group refusal rate was about 20%. 
                                                 
1 Australia is a very multicultural society and non-English-speaking households are common. It is important to note that while participants 
may not have spoken English as their first language at home this did not necessarily mean that they did not speak or understand English at 
all. Some patients in this category were given time and/or help to fill out the questionnaires. 
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Measures 
Dysexecutive functioning was assessed using the DEX (Wilson et al., 1996).  To 
examine the parsimony of the DEX models we employed the Zung Self-Rating Depression 
Scale (SDS) (Zung, 1965), the Beck Anxiety Inventory (BAI) (Beck, Epstein, Brown, & 
Steer, 1988), the Depression, Anxiety and Stress Scale (DASS), the General Self-efficacy 
Scale (GSES) and the Satisfaction with Life Scale (SWLS).  These tests are well established 
and are the most commonly used tests for both anxiety and mood disorders for clinical 
outcome studies (See also Oei & Boschen, 2009). 
Dysexecutive functioning. The DEX is a 20-item scale that measures a range of 
dysexecutive symptoms. It is structured on a five-point Likert scale ranging from 0 (never) to 
4 (very often), with higher scores indicating a greater severity of executive functioning 
problems.  The DEX was designed to sample the four broad areas of change associated with 
dysexecutive functioning in brain-injured patients: (1) emotional or personality, (2) 
motivational, (3) behavioral, and (4) cognitive changes (Picton & Stuss, 1994).  It was 
developed to supplement and provide ecological validity for the Behavioral Assessment of the 
Dysexecutive Syndrome (Wilson et al., 1996).   
There are two versions of the DEX, one that is completed by the participant (DEX-S) 
and the other which is completed by a significant other who knows the participant well and 
has frequent contact with them (DEX-O); this is typically a caregiver, relative, or friend.  In 
the present study the DEX-S was used for ease of administration and to allow for comparisons 
with previous research.  In addition, the DEX-S is favored over the DEX-O given the 
importance of obtaining a large sample size to conduct EFA (N = 300, Tabacknick & Fidell, 
2007), coupled with the convenience of obtaining self-report data which would allow for ease 
of data collection in terms of time and effort.   Furthermore, as a relative or significant other 
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has an intimate knowledge of a participant’s functional ability their personal involvement and 
vested interest may significantly bias the accuracy of their ratings (Gans, 1983).   
  The DEX requires less than five minutes to complete when it is self-administered and 
approximately 10 minutes when orally administered.  The DEX has been shown to have good 
internal consistency, with a Cronbach’s coefficient reported to be in excess of 0.91 for a 
group of brain-injured patients (Bennett et al., 2005).   In the current study the Cronbach’s 
alpha was 0.90 for the community sample, 0.91 for the psychiatric sample, and 0.91 for the 
neurologically impaired sample.    
Depression symptomatology.  The SDS (Zung, 1965) was used to measure 
depression symptomatology. This 20-item self-report questionnaire is widely used as a 
screening tool because it assesses the common characteristics of depression, including 
pervasive affective disturbances, physiological/somatic symptoms, and psychological 
symptoms.  Questions are anchored on a four-point Likert scale, ranging from 1 (a little of the 
time) to 4 (most of the time).  The SDS is a well-established scale with good reliability 
(Chronbach’s alpha = 0.88).  
Anxiety symptomatology. Anxiety symptomatology was measured using the BAI 
(Beck et al., 1988), a 21-item self-report measure designed to assess levels of anxious 
symptomatology experienced by the individual during the past week. The BAI is a widely-
used and validated measure for anxiety symptomatology with response options for each item 
ranging from 0 (not at all) to 3 (severe – I could barely stand it) (Beck et al., 1988).  A total 
score is computed by summing individual item scores, ranging from 0 to 63, with higher 
scores indicating greater levels of anxious symptomatology.  Internal consistency reliability 
was 0.94. 
Stress symptomatology. The DASS stress (DASS-S) scale (Lovibond & Lovibond, 
1995) was used to measure stress symptomatology.  The DASS-S is anchored on a four-point 
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Likert scale of 0 (did not apply to me at all) to 3 (applied to me very much, or most of the 
time).  The seven items measuring the subscale of “stress” (DASS-S) were used in the current 
study.  A Cronbach’s alpha of 0.81 and 0.90 has been previously reported for a normative 
sample that completed the 7- and 14-item “stress” scales respectively (Lovibond & Lovibond, 
1995).  
Self-efficacy. Self-efficacy was measured using the GSES (Sherer et al., 1982), a 17-
item self-report questionnaire that assesses an individual’s general sense of perceived self-
efficacy.  The GSES was anchored on a five-point Likert scale ranging from 1 (strongly 
agree) to 5 (strongly disagree), and thus the five-point version was administered to 
participants.  Cronbach’s reliability coefficient for a normative sample has been reported as 
ranging from 0.86 (Sherer et al., 1982) to 0.92 (Endler, Speer, Johnson, & Flett, 2001).  
Global life satisfaction. The SWLS (Diener, Emmons, Larsen, & Griffin, 1985) was 
used, which is a five-item self-report questionnaire that measures global levels of satisfaction 
with life according to idiosyncratic criteria (Shin & Johnson, 1978).  The SWLS is anchored 
on a seven-point Likert scale, with 1 (strongly disagree) to 7 (strongly agree).  It has 
favorable psychometric properties, with the scale’s internal consistency estimates ranging 
from 0.79 (Blais, Vallerand, Pelletier, & Briere, 1989) to 0.89 (Alfonso & Allison, 1992).   
 
Procedure 
 Prior to the research commencing ethical clearance was received in accordance with 
the ethical review processes of the universities and hospitals and within the guidelines of the 
Australian Government’s National Health and Medical Research Council.  Data were 
collected from individuals across three sites, encompassing community, psychiatric 
(depressed and anxiety patients), and neurologically impaired samples.  Prior to engaging in 
the research written informed consent was obtained from participants and they were informed 
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that their participation was voluntary and that all responses would remain confidential.  
Participants were not paid for their participation; however, first-year psychology students 
participated in the study for partial course credit.  Participants2 completed the questionnaires 
in the same order, with participation time ranging from 15 to 45 minutes.  
 
Results 
Preliminary Analyses 
Prior to undertaking various descriptive and inferential analyses variables were 
examined for accuracy of data entry, missing values, and the extent to which distributions 
satisfied the assumptions of parametric analysis.  Missing values were scattered randomly 
throughout the data and equated to less than 5% of responses for each variable; as such, they 
did not pose any methodological problems (Cohen & Cohen, 1983).  As a result, the listwise 
deletion default was used for the analyses.   
 
Factorial Validation of the DEX 
The first group (Subset A) comprised 469 participants (n = 331 community; n = 106 
psychiatric; n = 59 neurological).  There were 259 males (52.2%) and ages ranged from 15 to 
72 years (M = 29.2; SD = 13.5).  Subset B comprised 520 participants (n = 340 community; n 
= 124 psychiatric; n = 56 neurological).  There were 258 males (49.6%) and ages ranged from 
15 to 72 years (M = 30.4; SD = 14.2).  Age (t [1] = 0.64, ns) and gender (t [1] = -1.40, ns) 
were proportionately represented between the groups.  Subset A was used to determine the 
primary factor structure of the DEX using EFA, and to confirm the validity of previous EFA 
structures (i.e., Burgess et al., 1998; Chan, 2001; Mooney et al., 2006).  Subset B was used to 
                                                 
2 Some neurological participants were able to complete the questionnaire unassisted, whereas others required the researcher’s assistance (i.e., 
clarification of the meaning of a word, providing an everyday example to aid in interpretation, or by circling responses for participants where 
motor, reading, or visual difficulties were present).   
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conduct a series of CFAs that tested the validity of the factor structure determined via EFAs 
conducted using Subset A.  
Exploratory factor analysis via principle components with Subset A.  The 20 
items of the DEX were subjected to Principle Component Analysis (PCA).  Varimax rotation 
and Kaiser normalization were also used in order to allow comparisons with previous research 
(i.e., Burgess et al., 1998; Chan, 2001; Mooney et al., 2006).  Several criteria were employed 
to determine final factor structures: (1) minimum factor eigenvalues of 1, (2) exclusion of 
items with factor loadings less than 0.4, (3) exclusion of items with loadings greater than 0.4 
on more than one factor, and (4) conceptual consistency of specific clusters of items (this 
means sharing both statistical loading and conceptual meanings).   
Factor analysis of the 20-item DEX with Varimax rotation resulted in a three-
component solution, which explained a total of 51.48% of the variance; this solution yielded 
the most parsimonious solution (see Table 2).  This revised structure was labeled DEX-R.  
Factor 1 accounted for 36.87% (eigenvalue = 5.53) and was composed of six items (2, 3, 5, 9, 
16, and 17), with loadings ranging from 0.52 to 0.73.  Factor 1 assessed the dysexecutive 
symptoms of attention, impulsivity, and inhibition, and was labeled inhibition.  This factor 
was most similar to Mooney et al.’s (2006) inhibition and abstract problem solving factors.  
The second factor accounted for 9.06% of the variance (eigenvalue = 1.36) and had high 
loadings on seven items (1, 4, 8, 10, 11, 12, and 19), ranging from 0.43 to 0.76.  Factor 2 was 
labeled volition as it comprised items measuring the dysexecutive symptoms of volition, 
indecision, and emotional liability.  This factor appeared to correspond with Burgess et al.’s 
(1998) factors of intentionality, positive affect, and negative affect.  In addition, this factor 
was also similar to Chan’s (2001) factors of intentionality, knowing–doing dissociation, and 
social regulation. The third factor accounted for 7.26% of the variance (eigenvalue = 1.09) 
and comprised only two items (13 and 20), with factor loadings of 0.77 and 0.80 respectively.  
14 
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Factor 3 was labeled social regulation and appeared to correlate best with Burgess et al.’s 
(1998) inhibition factor.   
  Confirmatory factor analysis of the DEX-R.  The first series of CFAs attempted to 
fit the subscales of the DEX as revealed through the EFA on Subset A.  Each model is 
introduced, explained, and assessed in the following sections.  Models that use scales as their 
unit of analysis require some parameters in the model to be estimated in order to achieve 
identification.  Therefore, in line with recommendations of Jöreskog and Sörbom (1990), the 
error variance for each of the subscales was estimated using the subscale’s alpha reliability, 
which has been demonstrated to be a sound approximation in determining error variance 
(Netemeyer, Johnson, & Burton, 1990).  The second series of CFAs tested rival models 
(Burgess et al., 1998; Chan, 2001; Mooney et al., 2006; Wilson et al., 1996).  The results from 
the analyses of all models tested are summarized in Table 3.   
------------------------------------------------- 
Insert Tables 2 and 3 about here 
------------------------------------------------- 
Model 1: Three-factor model with 15 items. Using Subset B, the first model tested 
(Model 1) attempted to fit the 15 items of the DEX-R onto the three subscales.  For Model 1, 
items 2, 3, 5, 16, and 17 were predicted to load onto Factor 1: Inhibition; items 1, 4, 8, 10, 11, 
and 19 were predicted to load onto Factor 2: Volition; while items 13 and 20 were predicted 
to load onto Factor 3: Social Regulation.  This model was supported by the analysis.  As can 
be seen in Table 2, the Goodness of Fit Index (GFI), Comparative Fit Index (CFI), 
Incremental Fit Index (IFI), and Tucker-Lewis Index (TLI) were greater than 0.90, suggesting 
an adequate fit to the data (Bentler, 1995; Hu & Bentler, 1999; Marsh, 1993).  The Normative 
Fit Index (NFI) also approximated 0.90; however, Bentler (1999) has recommended that the 
CFI be the index of choice over the NFI.  The Root Mean Square Error of Approximation 
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(RMSEA) was 0.06, indicating a good fit to the data (Byrne, 2001; MacCallum, Browne, & 
Sugawara, 1996), with a statistically significant test of closeness-of-fit (p < .001).  Based on 
the Root Mean Square Residual (RMR) criterion, Model 1 fitted the data well with 
interrelationships hypothesized among the factors.   
Model 2: Three-factor model with 15 items and a second-order DEX factor. Kline 
(1998) proposed that in order for a CFA model with a second-order factor to be identified 
there must be at least three first-order factors, otherwise the direct effects of the second-order 
factor on the first-order factors or the disturbances might be under-identified.   
Using Subset B, Model 2 attempted to fit the 15 items of the DEX-R onto the three 
factors with a second-order latent variable of executive dysfunction.  For Model 2, items 2, 3, 
5, 16, and 17 were predicted to load onto Factor 1: Inhibition; items 1, 4, 8, 10, 11, and 19 
were predicted to load onto Factor 2: Volition; while items 13 and 20 were predicted to load 
onto Factor 3: Social Regulation.  All three factors were also predicted to load onto the latent 
executive.  This model was also supported by the analysis.  As shown in Table 2, the GFI, 
CFI, IFI, and TLI were greater than 0.90, suggesting an adequate fit to the data.  The NFI 
approximated 0.90; however, as stated above, Bentler (1999) has recommended that the CFI 
be the index of choice over the NFI.  The RMSEA was 0.06 also indicating a good fit to the 
data, with a statistically significant test of closeness-of-fit (p < .001).  Based on these RMR 
criteria, Model 2 fitted the data well, with interrelationships hypothesized among the factors 
(see Table 2).   
Model comparisons.  Model 1 and Model 2 were compared for statistical significance 
in order to assess whether the 15-item model (Model 1) or the 15-item model with a second-
order factor (Model 2) was required to model the DEX-R appropriately.  In assessing the 
extent to which each model exhibited an improvement in fit the difference in fit between the 
two models was examined.  Using Subset A, Model 1 (χ2 [87] = 248.97) was compared with 
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Model 2 (χ2 [87] = 248.97), yielding a non-significant χ2 value difference (∆χ2 [1] = 0, ns).  
This indicates that there is no statistically significant difference in model fit between Model 1 
and Model 2.  Based on conceptual coherence it was concluded that the two models are 
equally adequate in explaining the data, and Model 2 should be adopted as the model of 
choice given that the DEX is supposed to measure the components of executive dysfunction 
(where executive dysfunction is a second-order factor). 
 
Confirmatory Factor Analyses—Testing Rival Models 
In CFA rival models should also be tested to assess their ability to fit the data 
(Thompson, 2004).  As such, a set of previously reported factor structures were tested.  Each 
model is introduced, explained, and assessed in the following sections.   
Model 3: Testing Wilson et al.’s (1996) Three-Factor Solution. Wilson et al. (1996) 
advocated a three-factor model where behavioral, cognitive, and emotional symptoms of 
executive dysfunction were considered as independent dimensions.  Using Subset A, Model 3 
was a three-factor model, similar to that proposed by Wilson et al.  This three-factor structure 
did not fit the current dataset (see Table 3).  
Model 4: Testing Burgess et al.’s (1998) Five-Factor Model. Burgess et al. (1998) 
favored a five-factor model, with factors labeled as inhibition, intentionality, executive 
memory, positive affect, and negative affect (Model 4).  This five-factor structure was not as 
effective as other models (i.e., Models 1 and 2, Subset A, see Table 3).  
Model 5: Testing Chan’s (2001) Five-Factor Model. Chan (2001) also reported a 
five-factor model, with the five factors labeled as inhibition, intentionality, knowing–doing 
dissociation, in-resistance, and social regulation (Model 5).  This five-factor structure was 
also not as effective as other models (i.e., Models 1 and 2, Subset A, see Table 3).  
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Model 6: Testing Mooney et al.’s (2006) Four-Factor Model. Mooney et al. (2006) 
reported a four-factor model, with the factors described as inhibition, intention, social 
regulation, and abstract problem solving (Model 6).  Mooney et al.’s four-factor model most 
closely approximated the current dataset (Subset A).  As illustrated in Table 3, for Model 6, 
the GFI, CFI, and IFI at best approximated 0.90, while RMSEA was 0.07. These indices 
suggest a mediocre fit to the data.   
Model 7: Generalizing Mooney et al.’s (2006) Four-Factor Model. Model 7 was 
validated by conducting a CFA using data from Subset B.  As illustrated in Table 3, the poor 
GFI indicates that this model did not fit the data well. 
 
Invariance Testing for the DEX-R 
Multiple group analysis (Jöreskog & Sörbom, 1990) was used to test for group 
invariance across sample characteristics (community, psychiatric, and neurological groups) 
and gender (male and female).  A comparison among sample groups between unconstrained 
[χ2(294) = 709.47, p <.01] and constrained [χ2(306) = 735.04, p <.01] models indicated a non-
significant difference [∆χ2(12) = 25.56, ns].  A comparison among gender groups between 
unconstrained [χ2(186) = 535.95, p <.01] and constrained [χ2(192) = 547.62, p <.01] models 
indicated a non-significant difference [∆χ2(6) = 11.67, ns], indicating our proposed DEX-R 
model has measurement invariance across groups (that is, when the model is applied across 
groups). 
 
Reliability of the DEX-R 
As internal consistency estimates for the DEX have only been reported in one 
previous study it is important to provide further evidence of the reliability of this 
questionnaire.  According to Tabachnick and Fidell (2007), a reliability coefficient of more 
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than 0.70 is sufficient to satisfy the requirements of internal consistency.  Checks for the 
internal consistency of the DEX revealed high reliability coefficients.  For all groups the 
combined (N = 997) estimate of internal consistency was 0.85, indicating that the 15-item 
DEX has high internal consistency.  Separate checks for internal consistency were performed 
for the subscales of the DEX.  Factor 1 yielded a Cronbach’s alpha of 0.80, while Factor 2 
had a Cronbach’s alpha of 0.75.  Factor 3 had a Cronbach’s alpha of 0.60; this could be due to 
the small number of items (two) on this factor and the fact that our sample was relatively 
homogeneous (Bernadi, 1994).       
 
Concurrent Validity of the DEX-R 
Table 4 displays the intercorrelations between the DEX-R Total Score and Factor 
Scores and other measures of well-being, including the SDS, BAI, DASS-S, GSES, and 
SWLS.  As can be seen from Table 4, the results show that the DEX-R total scores were 
significantly and positively correlated with total SDS, BAI, and DASS-S scores.  Similarly, 
the DEX-R total scores were negatively and significantly associated with the GSES and 
SWLS total scores.  Table 4 also shows that Factor 1 (Inhibition) and Factor 2 (Volition) of 
the DEX-R were significantly positively correlated with the total scores for the SDS, BAI, 
and DASS-S, and were significantly negatively correlated with total scores for the GSES and 
SWLS.  Furthermore, Factor 3 (Social Regulation) of the DEX-R was significantly positively 
correlated with the total score of the BAI and significantly negatively correlated with total 
scores for the GSES and SWLS.  However, Factor 3 was not significantly related to the total 
scores for the SDS and DASS-S.  There is debate surrounding the stability of Factor 3; 
however, these results provide evidence for the concurrent validity of Factors 1 and 2 of the 
DEX-R.   
---------------------------------------------- 
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INSERT TABLE 4 HERE 
------------------------------------------------- 
Criterion-Related Validity of the DEX-R: Discriminant Function Analysis  
The discriminant validity of the DEX-R was examined by observing group differences 
on the total score of the questionnaire.  Discriminant function analysis using the revised factor 
structure of the DEX was performed to determine its ability to classify community, 
psychiatric, and neurological groups in terms of deficits in executive functioning.  Using all 
groups combined (N = 997), the DEX-R Total Score was able to correctly classify 68.6% of 
cases (λ = 0.90, χ2 [2] = 102.51, F [2.990] = 54.00, p < .001).  Our results revealed that the 
DEX-R Total Score was able to predict group membership with the majority of the 
community group and correctly classify almost a quarter of the psychiatric group.    
 
Criterion Validity of the DEX-R Total Score 
A one-way between-groups ANOVA was performed to investigate group differences in self-
reported dysexecutive symptoms as measured by the DEX-R.  There was a statistically 
significant difference among the groups, F (3, 992) = 36.38, p < .001.   Means of executive 
dysfunction for each group were: community group = 19.49 (SD = 9.97); neurological group 
= 22.12 (SD = 13.94); and the psychiatric group, comprising the depressed group = 33.51 (SD 
= 14.68) and anxious group = 33.10 (SD = 14.05).  The post-hoc comparisons using the 
Games-Howell test indicated that the community group reported significantly fewer levels of 
dysexecutive syndrome than the depressed and anxious (psychiatric) groups.  Furthermore, 
the neurological group reported significantly lower levels of dysexecutive symptoms than the 
depressed and anxious groups.  However, there was no significant difference in dysexecutive 
symptoms between the community and neurologically impaired groups, as well as between 
the depression and anxiety groups.  In order to determine the sensitivity and specificity of the 
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DEX-R Total Score we ran a Receiver Operating Characteristics (ROC) analysis to determine 
the coordinate of sensitivity and specificity of the DEX-R.  Our ROC test results illustrated 
that the cut-off value of the DEX-R score was 37.50, with the ROC curve area = .712 (p<.001, 
STD error = .02), which gave us a good balance of sensitivity (0.9) and specificity (0.7) to 
correctly classify community, psychiatric, and neurological impaired groups. 
 
Discussion 
 The results from the EFA and CFA showed the DEX-R three-factor model (the 
factors being inhibition, volition, and social regulation) with 15 items to be the most 
parsimonious model.  The three factors were not significantly related. We believe the three 
factors were solid and important but we cannot claim that they are the essence of executive 
function without further research.  According to standard consensus, results revealed that for 
all groups combined (N = 997) estimates of internal consistency were “high” for the DEX-R 
Total Score.  Results also revealed that Factors 1 and 2 yielded internal consistency estimates 
that were “moderate to high”.  However, Factor 3 yielded a “less than adequate” (Alpha 0.60) 
measure of internal consistency, but this is not surprising considering this factor only included 
two items.  Given that the internal consistency estimate for Factor 3 was deemed inadequate it 
would undoubtedly compromise the results obtained when using this factor in subsequent 
analyses, which is clearly a limitation of the current research.  Future research should attempt 
to increase the internal consistency of this factor by developing new items relating to social 
regulation and incorporating these into the existing DEX.  Subsequent factor analytic research 
should then also be completed to determine adequate psychometric properties of the 
questionnaire.  
The inhibition and volition factors were significantly positively correlated with the 
total scores for depression, anxiety, and stress, and significantly negatively correlated with the 
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total scores for self-efficacy and satisfaction with life.  These findings were expected and thus 
support the importance of executive functioning in patients with mood and anxiety disorders. 
Factor 3, social regulation, was found to correlate with only the total score of anxiety 
symptoms and was significantly negatively correlated with the total scores for self-efficacy 
and satisfaction with life (not depression and stress).  There are several possible explanations 
for this result: (1) this factor has only two items which may be an inadequate number of items 
to yield significant correlations (Thompson, 2004); (2) this factor has poor internal 
consistency, which may impact on the factor’s ability to yield significant correlations 
(Tabachnick & Fidell, 2007); and/or (3) the items that comprised this factor (i.e., 13: lack of 
concern, 20: no concern for social rules) may not actually be related to depression and stress.  
In conclusion, there is debate surrounding the stability of Factor 3; however, these results 
provide partial evidence for the concurrent validity of Factors 1 and 2 of the DEX-R.  Future 
research should assess concurrent validity by assessing the relationship between the DEX-R 
Total Score and Factor Scores with other psychometric questionnaires and specific 
neuropsychological tests of executive dysfunction.   
Our results also revealed that the DEX-R Total Score was able to predict group 
membership, correctly classifying the majority of the community group and almost a quarter 
of the psychiatric group.  However, no cases in the neurologically impaired sample were 
correctly assigned; most were misclassified as belonging to the community group, indicating 
that the specificity of the DEX may be limited.  This is a significant limitation of the present 
research.  There are a number of potential reasons to explain these results, which may be due 
to the demographics of the neurologically impaired sample, such as time since injury, injury 
severity, and location of injury.  No previous research has conducted Discriminant Factor 
analysis (DFA) of the DEX and thus comparisons cannot be made.  Future research should 
conduct DFA to further assess the discriminant ability of the DEX-R.  Despite the use of 
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separate groups for the EFA and CFA, the DFA was conducted on the combined sample.  In 
future, separate groups should be used for all analyses to avoid circular statistical methods.   
Our results also revealed that participants who reported high levels of executive 
dysfunction also reported high levels of depression, anxiety, and stress symptomatology 
(predictive validity).  More specifically, the community group reported significantly fewer 
dysexecutive symptoms than the psychiatric group.  Further, the neurological group reported 
significantly lower levels of dysexecutive symptoms than the psychiatric group.  One 
potential explanation for these results may be related to the moderate levels of comorbidity 
between neurological impairment and psychiatric disorders (Lucas & Addeo, 2006; Stordal, 
Morken, Mykletun, Neckelmann, & Dahl, 2008).  As the DEX has never been used to 
measure executive dysfunction in psychiatric populations there is no literature with which to 
compare these results.  Another potential explanation may be due to methodological 
constraints.  Future research is required to further assess the predictive validity of the DEX-R 
with particular emphasis on controlling comorbidity issues.  A further theoretical 
interpretation for these findings may be based on evidence that has found that emotionally 
distressed individuals often overestimate their level of impairment and are often “deficit 
focused” (Morgan, Schoenberg, Dorr, & Burke, 2002), while individuals with neurological 
conditions often under-report their level of impairment (Chaytor et al., 2006).  Therefore, 
these findings may be explained by a pattern of over-reporting (in the psychiatric group) and 
under-reporting (in the neurologically impaired group) of symptoms by these two samples.   
Further, we found that the community and neurologically impaired groups reported 
similar levels of dysexecutive symptoms. A number of variables may have contributed to 
explaining the non-significant difference between the community and neurological groups in 
terms of their self-reported dysexecutive symptoms.  The categorization of cognitive deficits 
associated with traumatic brain injury (TBI) is typically divided into four successive phases, 
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which are related to the temporal order of events subsequent to the injury: (1) coma, (2) 
confusion and post-traumatic amnesia, (3) recovery of cognitive functions, and (4) stable 
cognitive sequelae (Rao & Lyketsos, 2000).  In the current research more than three quarters 
of the neurologically impaired participants were tested more than two years following their 
injury, which corresponds to the final phase of cognitive recovery. This suggests that the 
neurological population used in the current research was most likely exhibiting “stable 
cognitive sequelae”, which may have impacted on the research results.  More specifically, 
these participants may have been exhibiting limited deficits in executive functioning due to 
the period of time tested since their injury (Lucas & Addeo, 2006). This may be a possible 
explanation for the non-significant difference in self-reported dysexecutive symptoms in the 
community and neurologically impaired groups.  Future research could attempt to address this 
limitation by recruiting TBI patients who have more recently acquired their injuries to 
eliminate the possibility of cognitive recovery (Rao & Lyketsos, 2000).  Nonetheless, we ran 
a ROC analysis to determine the coordinate of sensitivity and specificity of the DEX-R, the 
results of which illustrated that the cut-off value of the DEX-R score was 39.50 with a ROC 
curve area = .71 (p<.001), which gave us a good balance of sensitivity (0.9) and specificity 
(0.7) to correctly classify psychiatric and neurological impaired groups. 
 
Further Limitations 
One of the major strengths of this research is related to sample size, having employed 
two groups of participants to conduct the exploratory and confirmatory factor analyses.  
Nonetheless, our findings are limited to an Australian sample.  Further, in the current study it 
is noted that the psychiatric sample is older than the community sample.  As such, age effect 
was apparent in the DEX between the clinical and community groups, and this could 
confound the comparisons between the two groups.  However, we performed a group 
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difference test and found age (t [1] = 0.64, ns) and gender (t [1] = -1.40, ns). As age and 
gender were proportionately represented between the groups the confounding effect of these 
factors was not a significant issue in this study.   
In our study it appears that most participants were categorized as Moderate-Severe 
TBI (28 patients with Mild TBI, seven with Moderate TBI and 35 with Severe TBI), which is 
a clear limitation of the study.  Additional analyses were conducted using injury severity as a 
further grouping variable for the neurologically impaired sample to determine if group 
differences were evident between the community and neurologically impaired samples.  
Results remained unchanged, which may be due to the small number of brain-injured 
participants used in the analyses (Tabachnick & Fidell, 2007). 
Furthermore, medication could have been affecting the cognitive functioning of any of 
the psychiatric patients.  While some studies conclude that psychotropic medications are more 
likely to stabilize or reduce psychiatric symptoms, other medications may have sedative 
effects (e.g. Houghton et al., 1999; Mishara & Goldberg, 2004).  The use of medication to 
reduce symptoms would generally stabilize or improve cognitive functioning; however, the 
sedative effects of Benzodiazepines in anxiety patients, for example, may in fact have the side 
effect of slowing cognitive functioning. This may, therefore, have had a negative impact on 
the DEX scores.  Our earlier study showed that pre-existing medication in a study involving 
group cognitive behavior therapy did not detract from or enhance the outcome of symptoms in 
patients studied (Oei & Yeoh, 1999).  This finding was also replicated in the treatment of 
social phobia (Titov, Andrews, Choi, Schwencke, & Mahoney, 2008).  While our study 
cannot address this issue from a statistical standpoint we acknowledge that this could be a 
limitation of this study.  Future research should aim to include participants of similar age, 
equal group sizes, and discrete neurological conditions to control for such confounding 
variables.   
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Summary 
This is a unique study, examining the factor structures and psychometric properties of 
the DEX by exploring executive dysfunction in individuals with depression and anxiety, and 
thereby providing evidence for the clinical utility and generalizability of this questionnaire.  
As a whole, this study revealed that the DEX-R is predominately a valid and reliable 
instrument that can be used to measure executive deficits in community, psychiatric, and 
neurological populations.  Given that the DEX-R has been found to be psychometrically 
sound executive deficits in other psychiatric disorders, such as eating, and obsessive and 
compulsive disorders, should be explored in future research.  
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Table 1 
Comparison of Previous Exploratory Factor Analytic Structures of the DEX 
Item 
number  
Behavioral characteristic Wilson 
et al. 
(1996) 
Burgess 
et al. 
(1998) 
Chan 
(2001) 
 Mooney 
et al. 
(2006) 
1 Abstract thinking problems - Inh In-r  Abs 
2 Impulsivity Beh Inh Int  Imp 
3 Confabulation Cog Exe In-r  Abs 
4 Planning problems - Int Int  Soc 
5 Euphoria Emo Pos Inh  Imp/Abs 
6 Temporal sequencing deficits Cog Exe -  Abs 
7 Lack of insight and social awareness Beh Int Kno  Soc 
8 Apathy and lack of drive Emo Neg Kno  Soc 
9 Disinhibition Beh Inh Inh  Abs 
10 Variable motivation - Pos -  - 
11 Shallowing of affective responses Emo Neg Kno  Soc 
12 Aggression Beh Pos Soc  Imp 
13 Lack of concern Beh Inh Inh  Imp 
14 Perseveration Cog Exe In-r  Imp 
15 Restlessness-hyperkinesis Beh Inh Inh  Imp 
16 Inability to inhibit responses Beh Inh Inh  Imp/Soc 
17 Knowing–doing dissociation - Int Kno  Int 
18 Distractibility Cog Int Int  Int 
19 Poor decision-making ability Cog Int Int  Int 
20 No concern for social rules Beh Inh Soc  Soc 
 
Note. Beh = Behavior, Cog = Cognition, Emo = Emotion, Inh = Inhibition, Int = Intentionality, Exe = 
Executive Memory, Pos = Positive Affect, Neg = Negative Affect, Kno = Knowing–doing Dissociation, 
In-r = In-resistance, Soc = Social Regulation, Abs = Abstract Problem Solving. 
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Table 2 
 
Factor Loadings in Response to the 15-item DEX-R (N = 997) 
Factors and items 
Factor loadings 
1 2 3 
Factor 1 – Inhibition 
   
  3.  Confabulation 0.73 
  
17.  Knowing–doing dissociation 0.71 
  
16.  Inability to inhibit responses 0.68 
  
  5.  Euphoria 0.68 
  
  2.  Impulsivity 0.64 
  
  9.  Disinhibition 0.52 
  
Factor 2 – Volition 
   
  8.  Apathy and lack of drive 
 
0.78 
 
  4.  Planning problems 
 
0.73 
 
19.  Poor decision making ability 
 
0.67 
 
11.  Shallowing of affective responses 
 
0.60 
 
  1.  Abstract thinking problems 
 
0.59 
 
10.  Variable motivation 
 
0.59 
 
12.  Aggression 
 
0.43 
 
Factor 3 – Social regulation 
   
20.  No concern for social rules 
  
0.80 
13.  Lack of concern 
  
0.77 
Variance explained (Alpha) 36.87(.80) 9.06(.81) 7.26(.57) 
Note. Cross loadings less than 0.4 are not displayed.    
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Table 3 
Summary Table of Results from Confirmatory Factor Analyses 
 
Model 
 
 
χ2 
 
df 
 
χ2/df 
 
NFI 
 
GFI 
 
CFI 
 
IFI 
 
TLI 
 
RMSEA 
 
RMR 
 
Goodness of fit cut-offs 
 
Independence model 
 
Original models tested (Subset B) 
 
1: 3-factor model with 15 items 
2: Model 1 with second-order DES factor  
 
Rival models tested (Subset A) 
 
3: Wilson et al.’s (1996) 3-factor solution  
4: Burgess et al.’s (1998) 5-factor model  
5: Chan’s (2001) 5-factor model  
6: Mooney et al.’s (2006) 4-factor model  
7: Generalisation of model 6 to Subset B 
 
 
- 
 
248.97 
 
 
 
248.97 
248.97 
 
 
 
630.65 
1432.22 
490.53 
500.78 
554.52 
 
- 
 
87 
 
 
 
87 
87 
 
 
 
102 
164 
125 
145 
145 
 
<4 
 
2.86 
 
 
 
2.86 
2.86 
 
 
 
6.18 
8.73 
3.92 
3.45 
3.82 
 
≥0.90 
 
0.00 
 
 
 
0.90 
0.90 
 
 
 
0.76 
0.63 
0.85 
0.86 
0.85 
 
≥0.90 
 
0.41 
 
 
 
0.94 
0.94 
 
 
 
0.87 
0.79 
0.89 
0.90 
0.89 
 
≥0.90 
 
0.00 
 
 
 
0.93 
0.93 
 
 
 
0.79 
0.65 
0.88 
0.89 
0.88 
 
≥0.90 
 
0.00 
 
 
 
0.93 
0.93 
 
 
 
0.79 
0.65 
0.88 
0.89 
0.88 
 
≥0.90 
 
0.00 
 
 
 
0.91 
0.91 
 
 
 
0.75 
0.60 
0.85 
0.87 
0.86 
 
 
≤0.08 
 
0.21 
 
 
 
0.06*** 
0.06*** 
 
 
 
0.10 
0.13 
0.08 
0.07*** 
0.07 
 
≤0.08 
 
0.34 
 
 
 
0.05 
0.05 
 
 
 
0.19 
0.30 
0.06 
0.06 
0.06 
Note.  χ2 = minimum discrepancy; df = degrees of freedom; NFI = Normed Fit Index; GFI = Goodness of Fit Index; CFI = Comparative Fit 
Index; IFI = Incremental Fit Index; TLI = Tucker-Lewis Index; RMSEA = Root Mean Square Error of Approximation; RMR = Root Mean 
Square Residual. *** p < .001. 
 
1 
PSYCHOMETRIC VALIDATION OF THE DEX 
 
Table 4  
Bi-variate Correlations between DEX-R Total Score and Factor Scores and the BAI, SDS, 
DASS-S, GSES and SWLS  
 SDS BAI DASS-S GSES SWLS 
Total Score 
N 
 
Factor 1 
n 
0.54** 
966 
 
0.17** 
965 
0.62** 
610 
 
0.35** 
609 
0.58** 
610 
 
0.32** 
609 
-0.66** 
600 
 
-0.32** 
599 
-0.47** 
606 
 
-0.11** 
605 
Factor 2 
n 
0.66** 
965 
0.57** 
609 
0.56** 
609 
-0.67** 
599 
-0.56* 
605 
Factor 3 
n 
0.03 
965 
0.10* 
609 
0.08 
609 
-0.08* 
599 
-0.11** 
605 
      
*p < .05.  **p < .01 
